Category Archives: Macular Degeneration

  • 0

Novartis receives FDA approval for Beovu®, offering wet AMD patients a new option

Basel, October 8, 2019 — Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Beovu® (brolucizumab) injection, also known as RTH258 for the treatment of wet age-related macular degeneration (AMD)[1]. Beovu is the first FDA approved anti-VEGF to offer both greater fluid resolution versus aflibercept and the ability to maintain eligible wet AMD patients on a three-month dosing interval immediately after a three-month loading phase[1] with uncompromised efficacy.

Read the full press release


  • 0

Welcome Dr. Birva K. Shah

Dr. Lipschultz Welcomes Dr. Birva K. Shah to Southland Eye!

Dr. Lipschultz is proud to announce, and welcome, Dr. Birva K. Shah to the practice, beginning in the November of 2019.

Dr. Shah is a residency trained optometrist, specializing in pediatric and contact lens care. She has extensive experience with binocular vision disorders, including strabismus, amblyopia, and convergence/accommodative disorders.  She also has extensive training in specialty contact lenses, scleral contact lenses, and diagnosis and management of glaucoma, macular degeneration and diabetic eye disease.

Dr. Shah grew up on the western suburbs of Chicago, attended the Illinois College of Optometry in Chicago, is married, and has one lovely daughter.


  • 0

Self-Testing for Macular Degeneration Falls Short

Tags : 

macular degenerationConsumers who want to know their risk of developing age-related macular degeneration can shell out between $99 and $1100 for a commercial DNA test, but at least four tests marketed directly to consumers promise more than they can deliver.  READ MORE…